Only all-cause mortality seemed to be partially affected by differences in low-grade tumors between ARID1A+ and ARID1A− as well as by different cancer types, i.e., gastrointestinal/gynecological vs. urological cancers. The gene discussed is ARID1A; the disease is cancer.